AcrySof toric IOL offers spectacle independence

Article

The AcrySof toric intraocular lens (IOL) (Alcon) offers greater spectacle independence than the monofocal AcrySof SA60AT single-piece IOL (Alcon).

The AcrySof toric intraocular lens (IOL) (Alcon) offers greater spectacle independence than the monofocal AcrySof SA60AT single-piece IOL (Alcon), according to Paul Ernest from Jackson, USA.

Dr Ernest enrolled 480 patients and randomized them to receive either the control lens, AcrySof SA60AT single piece IOL (n=237), or the AcrySof toric IOL (n=243). Each patient had at least 0.75 D of regular astigmatism and age-related cataracts in one or both eyes.

The toric IOL patients reported a significantly greater rate of spectacle independence than controls (p<0.0001). Compared with controls, the percentage of toric patients achieving an uncorrected distance visual acuity (UDCVA) of 20/20 or better (19.4% versus 40.7%, respectively) or 20/25 or better (41.4% versus 63.7%, respectively) was significant (p<0.0001).

The comparison of the lenses demonstrates that the AcrySof toric IOL offers a much greater level of spectacle independence than its monofocal counterpart.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Recent Videos
Jay Chhablani, MD, shares late-breaking data from the ArMaDa trial, investigating gene therapy for Geographic Atrophy and dry age-related macular degeneration, at EURETINA
Editorial advisory board member Alexandra Miere, MD, PhD, speaks about the ACTOR and HERMES studies at the 2025 European Society of Retina Specialists (EURETINA) Congress
María Berrocal, MD, speaks about the Vit-Buckle Society symposium hosted at the 2025 European Society of Retina Specialists (EURETINA) annual meeting
© 2025 MJH Life Sciences

All rights reserved.